Wall Street analysts project Oshkosh (OSK) to report Q2 earnings of $2.98 per share, a 10.8% year-over-year decline, on revenues of $2.65 billion, down 7%, with the consensus EPS estimate recently revised 1.4% lower. While the Vocational segment anticipates robust sales growth of 13.9% and increased operating income, the Access segment is expected to face significant year-over-year declines in sales and operating income. Despite these mixed segment forecasts and overall revenue/EPS contraction, OSK shares have outperformed the broader market, gaining 14.1% over the past month against the S&P 500's 3.6% rise.
Wall Street consensus forecasts for Oshkosh's (OSK) upcoming Q2 report indicate a challenging quarter, with projected year-over-year declines in both revenue by 7% to $2.65 billion and earnings per share by 10.8% to $2.98. This outlook is further shaded by a 1.4% downward revision to the consensus EPS estimate over the last 30 days, signaling weakening analyst conviction. A detailed look at segment-level expectations reveals a significant divergence in performance. The Vocational segment is a bright spot, with analysts forecasting a 13.9% increase in net sales to $960.02 million and a substantial rise in adjusted operating income. Conversely, the Access and Defense segments are expected to be significant drags on performance. The Access segment, the company's largest, is projected to see sales fall by 15.8% and adjusted operating income contract sharply to $160.28 million from $248.80 million in the prior year. The Defense segment faces the steepest revenue decline at an estimated 22.7%, although its adjusted operating income is surprisingly forecast to increase. Despite these bearish fundamental projections, OSK shares have rallied 14.1% over the past month, dramatically outperforming the S&P 500, which suggests the market may be anticipating an earnings beat or bullish forward guidance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment